Filing Details

Accession Number:
0001628280-24-011050
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-03-13 21:21:40
Reporting Period:
2024-03-11
Accepted Time:
2024-03-13 21:21:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1671284 Neuehealth Inc. NEUE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1381037 Iii Lawrence George Mikan C/O Neuehealth, Inc.
8000 Norman Center Drive, Suite 900
Minneapolis MN 55437
Ceo & President Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-03-11 2,664 $8.11 80,723 No 4 S Direct
Common Stock Disposition 2024-03-12 1,598 $7.76 79,125 No 4 S Direct
Common Stock Disposition 2024-03-13 3,463 $7.30 75,662 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. These shares were sold by the reporting person to cover tax withholding obligations upon the vesting of restricted stock units and were not discretionary transactions by the reporting person.
  2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.85 and $8.38 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.40 and $8.10 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.11 and $7.52 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.